Rezultati pretraživanja
  1. prije 20 sati
  2. prije 20 sati

    , Take a look at this new advent of MJ giant conglomerate, from seed, farm, distribution and banking, it will be a parabolic investment for your life-changer, 👍👍👍

  3. prije 20 sati

    The largest MJ Holding company, has started closing LOIs!!! MJ Investors in Join us!!! The liftoff has just begun! Looking at potential returns greater than 50,000%!!!

  4. 41 analysts who cover Uber28 have buy or overweight/ating13 have hold ratingsand 0 have a sell rating with an average price target of $45.51.

    Prikaži ovu nit
  5. Guggenheim analyst Jake Fuller said in a Jan23 note that increased price target to $45 from$40.

  6. 4. velj
    Prikaži ovu nit
  7. 4. velj

    Ready to take off. Charts looks prime.

  8. 3. velj

    Biotech updates 02/03: Ph2 +ve data +41% Fast track desig+15% offering -12% AH Phase 2/3 SCLC fail -2% 1:20 reverse split (02/11) Pipeline updates:

  9. 3. velj

    : New Insider Filing on President TERRI B SEBREE:

  10. Rosenberger Brian (VP, Commercial & Business Dev.) acquired new securities, reported in a new form 4 filed with the SEC

  11. 3. velj

    Laden With Screening Now Closed, Pivotal FXS and 2 Phase 2s due Q2; Reit Buy, $26 PT screening in its most advanced clinical-stage program, CONNECT-FX, has now closed.looking for pivotal results from Zynerba’s Zygel (2% cannabidiol [CBD] gel) in June (guidance is “late Q2

  12. 3. velj

    Currently a good price for . Maybe a little lower to go, but overall it is fair game at this point

  13. 3. velj

    BUY and everyone in biotechs should have these on close watch.

  14. 1. velj

    In an exclusive interview with the Fly, Valens sees consistency, overall quality as challenges facing the industry. "More in “Rising High,” weekly from

  15. 31. sij
    Prikaži ovu nit
  16. 31. sij

    Zynerba Pharmaceuticals Upgraded by ValuEngine to Hold

  17. 30. sij

    Rising High: An exclusive talk with product manufacturing company Valens

  18. 29. sij

    LOOKS TO BE GEARING UP FOR A BIG RUN. let’s hear some data. Still think this stock could go to $20 on good results from Zygel.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.